Innovations in Actinic Keratosis.
Lyle RE, Tran LH, Eisen DB.
Dermatol Clin. 2025 Jan;43(1):77-94. doi: 10.1016/j.det.2024.08.006. Epub 2024 Oct 20.
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments.
Li Z, Lu F, Zhou F, Song D, Chang L, Liu W, Yan G, Zhang G.
Front Immunol. 2025 Jan 24;16:1518633. doi: 10.3389/fimmu.2025.1518633. eCollection 2025.
Actinic keratosis and imiquimod: a review of novel carriers and patents.
Sharma M, Sharma G, Singh B, Katare OP.
Expert Opin Drug Deliv. 2019 Feb;16(2):101-112. doi: 10.1080/17425247.2019.1560418. Epub 2018 Dec 24.
Actinic Keratosis: Current Therapies and Insights Into New Treatments.
Hashim PW, Chen T, Rigel D, Bhatia N, Kircik LH.
J Drugs Dermatol. 2019 May 1;18(5):s161-166..
Actinic keratosis epidemiology: the good, the bad and the ugly.
Naldi L, Cassalia F.
Br J Dermatol. 2024 Mar 15;190(4):457-458. doi: 10.1093/bjd/ljad395.
Tirbanibulin for the Treatment of Actinic Keratosis: A Review.
Miller AC, Adjei S, Temiz LA, Tyring SK.
Skin Therapy Lett. 2022 Jul;27(4):4-7.
Managing actinic keratosis in primary care.
Salmon N, Tidman MJ.
Practitioner. 2016 Oct;260(1797):25-9.
Actinic Keratosis Pathogenesis Update and New Patents.
Cantisani C, Paolino G, Melis M, Faina V, Romaniello F, Didona D, Cardone M, Calvieri S.
Recent Pat Inflamm Allergy Drug Discov. 2016;10(1):40-48. doi: 10.2174/1872213x10666160504104825.
Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.
Grada A, Feldman SR, Bragazzi NL, Damiani G.
Dermatol Ther. 2021 Mar;34(2):e14833. doi: 10.1111/dth.14833. Epub 2021 Feb 21.
What lies beneath actinic keratosis? Looking beyond visible lesions to optimize patient outcomes.
Lear JT.
J Eur Acad Dermatol Venereol. 2017 Mar;31 Suppl 2:3-4. doi: 10.1111/jdv.14109.
